The thyroid hormones and their nuclear receptors in the gut: From developmental biology to cancer

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 8, 2011, Pages 938-946

  Sirakov, Maria ^a   Plateroti, Michelina ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Intestinal development; Intestinal tumor; Stem cells; Thyroid hormone; Thyroid hormone receptor TR

Indexed keywords

DNA; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA1; THYROID HORMONE RECEPTOR ALPHA2; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; THYROID HORMONE RECEPTOR BETA2; THYROID HORMONE RECEPTOR BETA3; UNCLASSIFIED DRUG;

CARCINOGENESIS; DEVELOPMENTAL BIOLOGY; DNA SEQUENCE; GENE MUTATION; HORMONAL REGULATION; HUMAN; INTESTINE ABSORPTION; INTESTINE CANCER; INTESTINE DEVELOPMENT; INTESTINE EPITHELIUM; METAMORPHOSIS; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE BINDING SITE; ORGANOGENESIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DNA BINDING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; RECEPTORS, THYROID HORMONE; THYROID HORMONES;

AMPHIBIA; MAMMALIA; VERTEBRATA;

EID: 79958275825     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.12.020     Document Type: Review

References (110)

1. Fredric E.a.W., M. Lessons learned from TR-beta mutant mice. Syndromes of Hormone Resistance on the Hypothalamic-Pituitary-Thyroid Axis 2004, 109-118. Kluwer Academic Publishers. P. Beck-Peccoz (Ed.).
2. Lazar M.A. Thyroid hormone action: a binding contract. J. Clin. Invest. 2003, 112(4):497-499.
3. Brent G. The molecular basis of thyroid hormone action. N. Engl. J. Med. 1994, 331:847-853.
4. Bianco A.C., Kim B.W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 2006, 116(10):2571-2579.
5. Dumitrescu A.M., et al. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 2006, 147(9):4036-4043.
6. Refetoff S., Dumitrescu A.M. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21(2):277-305.
7. Friesema E.C., et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004, 364(9443):1435-1437.
8. Visser T.J. Thyroid hormone transporters. Horm. Res. 2007, 68(Suppl 5):28-30.
9. Laudet V., et al. Evolution of the nuclear receptor gene superfamily. EMBO J. 1992, 11(3):1003-1013.
10. Mangelsdorf D.J., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839.
11. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001, 81(3):1097-1142.
12. Gonzalez-Sancho J.M., et al. Thyroid hormone receptors/THR genes in human cancer. Cancer Lett. 2003, 192(2):121-132.
13. Andersson M.L., Vennstrom B. Chicken thyroid hormone receptor alpha requires the N-terminal amino acids for exclusive nuclear localization. FEBS Lett. 1997, 416(3):291-296.
14. Yen P.M., et al. Thyroid hormone action at the cellular, genomic and target gene levels. Mol. Cell. Endocrinol. 2006, 246(1-2):121-127.
15. Hartong R., et al. Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ ATPase gene. Demonstration that retinoid X receptor binds 5' to thyroid hormone receptor in response element 1. J. Biol. Chem. 1994, 269(17):13021-13029.
16. Wu W., Niles E.G., LoVerde P.T. Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni. BMC Evol. Biol. 2007, 7:150.
17. Paris M., et al. The amphioxus genome enlightens the evolution of the thyroid hormone signaling pathway. Dev. Genes Evol. 2008, 218(11-12):667-680.
18. Voss S.R., et al. Candidate gene analysis of thyroid hormone receptors in metamorphosing vs. nonmetamorphosing salamanders. Heredity 2000, 85(Pt 2):107-114.
19. Helbing C.C., et al. Isolation of the alligator (Alligator mississippiensis) thyroid hormone receptor alpha and beta transcripts and their responsiveness to thyroid stimulating hormone. Gen. Comp. Endocrinol. 2006, 149(2):141-150.
20. Nelson E.R., Habibi H.R. Molecular characterization and sex-related seasonal expression of thyroid receptor subtypes in goldfish. Mol. Cell. Endocrinol. 2006, 253(1-2):83-95.
21. Marchand O., et al. Molecular cloning and characterization of thyroid hormone receptors in teleost fish. J. Mol. Endocrinol. 2001, 26(1):51-65.
22. Safi R., et al. Thyroid hormone receptor genes of neotenic amphibians. J. Mol. Evol. 1997, 44(6):595-604.
23. Safi R., et al. The axolotl (Ambystoma mexicanum), a neotenic amphibian, expresses functional thyroid hormone receptors. Endocrinology 2004, 145(2):760-772.
24. Shi Y.B., Ishizuya-Oka A. Thyroid hormone regulation of apoptotic tissue remodeling: implications from molecular analysis of amphibian metamorphosis. Prog. Nucleic Acid Res. Mol. Biol. 2001, 65:53-100.
25. Bassett J.H., Williams G.R. The molecular actions of thyroid hormone in bone. Trends Endocrinol. Metab. 2003, 14(8):356-364.
26. Koenig R.J., et al. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 1989, 337(6208):659-661.
27. Chassande O., et al. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol. Endocrinol. 1997, 11(9):1278-1290.
28. Plateroti M., et al. Functional interference between thyroid hormone receptor alpha (TRalpha) and natural truncated TRDeltaalpha isoforms in the control of intestine development. Mol. Cell. Biol. 2001, 21(14):4761-4772.
29. Flamant F., Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol. Metab. 2003, 14(2):85-90.
30. Harvey C.B., et al. The rat thyroid hormone receptor (TR) Deltabeta3 displays cell-, TR isoform-, and thyroid hormone response element-specific actions. Endocrinology 2007, 148(4):1764-1773.
31. Williams G.R. Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Mol. Cell. Biol. 2000, 20(22):8329-8342.
32. Henning S., Rubin D., Shulman J. Ontogeny of the intestinal mucosa. Physiology of the Gastrointestinal Tract 1994, 571-601. Raven Press, New York. J. LR (Ed.).
33. Heimeier R.A., et al. Studies on Xenopus laevis intestine reveal biological pathways underlying vertebrate gut adaptation from embryo to adult. Genome Biol. 2010, 11(5):R55.
34. Ishizuya-Oka A., Shi Y.B. Molecular mechanisms for thyroid hormone-induced remodeling in the amphibian digestive tract: a model for studying organ regeneration. Dev. Growth Differ. 2005, 47(9):601-607.
35. Kress E., et al. The thyroid hormone receptor-alpha (TRalpha) gene encoding TRalpha1 controls deoxyribonucleic acid damage-induced tissue repair. Mol. Endocrinol. 2008, 22(1):47-55.
36. Kress E., Samarut J., Plateroti M. Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality?. Mol. Cell. Endocrinol. 2009, 313(1-2):36-49.
37. Randall D., Burggren W., French K. Eckert Animal Physiology: Mechanisms and Adaptation 2002, Freeman and Company, New York.
38. Porter E.M., et al. The multifaceted Paneth cell. Cell. Mol. Life Sci. 2002, 59(1):156-170.
39. van der Flier L.G., Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 2009, 71:241-260.
40. Stappenbeck T.S., et al. Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. Curr. Opin. Cell Biol. 1998, 10(6):702-709.
41. Ishizuya-Oka A., Hasebe T. Sonic hedgehog and bone morphogenetic protein-4 signaling pathway involved in epithelial cell renewal along the radial axis of the intestine. Digestion 2008, 77(Suppl 1):42-47.
42. Sancho E., Batlle E., Clevers H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 2004, 20:695-723.
43. Buchholz D.R., et al. Pairing morphology with gene expression in thyroid hormone-induced intestinal remodeling and identification of a core set of TH-induced genes across tadpole tissues. Dev. Biol. 2007, 303(2):576-590.
44. Ishizuya-Oka A., et al. Thyroid hormone-induced expression of sonic hedgehog correlates with adult epithelial development during remodeling of the Xenopus stomach and intestine. Differentiation 2001, 69(1):27-37.
45. Kress E., et al. The frizzled-related sFRP2 gene is a target of thyroid hormone receptor alpha1 and activates beta-catenin signaling in mouse intestine. J. Biol. Chem. 2009, 284(2):1234-1241.
46. Schreiber A.M., et al. Diverse developmental programs of Xenopus laevis metamorphosis are inhibited by a dominant negative thyroid hormone receptor. Proc. Natl Acad. Sci. USA 2001, 98(19):10739-10744.
47. Leloup J., Buscaglia M. La triiodothyronine, hormone de la metamorphose des amphibiens. C.R. Acad. Sci. Paris 1977, 284D:1161-2163.
48. Boorse G.C., Denver R.J. Expression and hypophysiotropic actions of corticotropin-releasing factor in Xenopus laevis. Gen. Comp. Endocrinol. 2004, 137(3):272-282.
49. Furlow J.D., Neff E.S. A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends Endocrinol. Metab. 2006, 17(2):40-47.
50. Tata J.R. Amphibian metamorphosis as a model for the developmental actions of thyroid hormone. Mol. Cell. Endocrinol. 2006, 246(1-2):10-20.
51. Ishizuya-Oka A., Shi Y.B. Thyroid hormone regulation of stem cell development during intestinal remodeling. Mol. Cell. Endocrinol. 2008, 288(1-2):71-78.
52. Brown D.D., Cai L. Amphibian metamorphosis. Dev. Biol. 2007, 306(1):20-33.
53. Marshall J.A., Dixon K.E. Cell specialization in the epithelium of the small intestine of feeding Xenopus laevis tadpoles. J. Anat. 1978, 126(Pt 1):133-144.
54. Schreiber A.M., Cai L., Brown D.D. Remodeling of the intestine during metamorphosis of Xenopus laevis. Proc. Natl Acad. Sci. USA 2005, 102(10):3720-3725.
55. Ishizuya-Oka A., Shimozawa A. Programmed cell death and heterolysis of larval epithelial cells by macrophage-like cells in the anuran small intestine in vivo and in vitro. J. Morphol. 1992, 213(2):185-195.
56. Su Y., et al. Molecular and cellular basis of tissue remodeling during amphibian metamorphosis. Histol. Histopathol. 1999, 14(1):175-183.
57. Shi Y.B., Brown D.D. The earliest changes in gene expression in tadpole intestine induced by thyroid hormone. J. Biol. Chem. 1993, 268(27):20312-20317.
58. Yaoita Y., Brown D.D. A correlation of thyroid hormone receptor gene expression with amphibian metamorphosis. Genes Dev. 1990, 4(11):1917-1924.
59. Kanamori A., Brown D.D. The regulation of thyroid hormone receptor beta genes by thyroid hormone in Xenopus laevis. J. Biol. Chem. 1992, 267(2):739-745.
60. Shi Y.B., Ishizuya-Oka A. Autoactivation of Xenopus thyroid hormone receptor beta genes correlates with larval epithelial apoptosis and adult cell proliferation. J. Biomed. Sci. 1997, 4(1):9-18.
61. Rubin D.C. Intestinal morphogenesis. Curr. Opin. Gastroenterol. 2007, 23(2):111-114.
62. Hadj-Sahraoui N., et al. Hypothyroidism prolongs mitotic activity in the post-natal mouse brain. Neurosci. Lett. 2000, 280(2):79-82.
63. Matosin-Matekalo M., et al. Glucose and thyroid hormone co-regulate the expression of the intestinal fructose transporter GLUT5. Biochem. J. 1999, 339(Pt 2):233-239.
64. Jumarie C., Malo C. Alkaline phosphatase and peptidase activities in Caco-2 cells: differential response to triiodothyronine. In Vitro Cell. Dev. Biol. Anim. 1994, 30A(11):753-760.
65. Plateroti M., et al. Involvement of T3Ralpha- and beta-receptor subtypes in mediation of T3 functions during postnatal murine intestinal development. Gastroenterology 1999, 116(6):1367-1378.
66. Flamant F., et al. Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. Mol. Endocrinol. 2002, 16(1):24-32.
67. Gauthier K., et al. Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus. Mol. Cell. Biol. 2001, 21(14):4748-4760.
68. Plateroti M., et al. Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells. Mol. Cell. Biol. 2006, 26(8):3204-3214.
69. Freund J.N., et al. The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem. Cell Biol. 1998, 76(6):957-969.
70. Ishizuya-Oka A., et al. Origin of the adult intestinal stem cells induced by thyroid hormone in Xenopus laevis. FASEB J. 2009, 23(8):2568-2575.
71. Lemkine G.F., et al. Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. FASEB J. 2005, 19(7):863-865.
72. Hasebe T., et al. Thyroid hormone-up-regulated hedgehog interacting protein is involved in larval-to-adult intestinal remodeling by regulating sonic hedgehog signaling pathway in Xenopus laevis. Dev. Dyn. 2008, 237(10):3006-3015.
73. Ishizuya-Oka A., et al. Thyroid hormone-upregulated expression of Musashi-1 is specific for progenitor cells of the adult epithelium during amphibian gastrointestinal remodeling. J. Cell Sci. 2003, 116(Pt 15):3157-3164.
74. Kayahara T., et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 2003, 535(1-3):131-135.
75. Potten C.S., et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003, 71(1):28-41.
76. He X.C., et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 2004, 36(10):1117-1121.
77. Montgomery R.K., Breault D.T. Small intestinal stem cell markers. J. Anat. 2008, 213(1):52-58.
78. Barker N., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457(7229):608-611.
79. Brabletz S., Schmalhofer O., Brabletz T. Gastrointestinal stem cells in development and cancer. J. Pathol. 2009, 217(2):307-317.
80. Scoville D.H., et al. Current view: intestinal stem cells and signaling. Gastroenterology 2008, 134(3):849-864.
81. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327(5965):542-545.
82. Potten C.S., et al. The stem cells of small intestinal crypts: where are they?. Cell Prolif. 2009, 42(6):731-750.
83. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40(7):915-920.
84. Potten C.S. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1998, 353(1370):821-830.
85. Potten C.S., Booth C. The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp. Biochem. Physiol. Biochem. Mol. Biol. 1997, 118(3):473-478.
86. Rezza, A., et al., The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci. 123 (Pt 19) (2010) 3256-3265.
87. Gregorieff A., Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005, 19(8):877-890.
88. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307(5717):1904-1909.
89. Brittan M., Wright N.A. Stem cell in gastrointestinal structure and neoplastic development. Gut 2004, 53(6):899-910.
90. van Es J.H., et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435(7044):959-963.
91. Fre S., et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl Acad. Sci. USA 2009, 106(15):6309-6314.
92. Horkko T.T., et al. Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. Int. J. Cancer 2006, 118(7):1653-1659.
93. Cheng S.Y. Thyroid hormone receptor mutations in cancer. Mol. Cell. Endocrinol. 2003, 213(1):23-30.
94. Rose D.P., Davis T.E. Plasma thyronine levels in carcinoma of the breast and colon. Arch. Intern. Med. 1981, 141(9):1161-1164.
95. Wang C.S., Lin K.H., Hsu Y.C. Alterations of thyroid hormone receptor alpha gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer. Cancer Lett. 2002, 175(2):121-127.
96. Iishi H., et al. Enhancement by thyroxine of experimental carcinogenesis induced in rat colon by azoxymethane. Int. J. Cancer 1992, 50(6):974-976.
97. Lin K.H., et al. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma. Endocrinology 1997, 138(12):5308-5315.
98. Lin K.H., et al. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha1 and beta1 receptors in a human hepatocellular carcinoma cell line. Endocrinology 1996, 137(10):4073-4081.
99. Kress E., et al. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 2010, 138(5):1863-1874.
100. Fodde R., et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA 1994, 91(19):8969-8973.
101. McCart A.E., Vickaryous N.K., Silver A. Apc mice: models, modifiers and mutants. Pathol. Res. Pract. 2008, 204(7):479-490.
102. Moehren U., Eckey M., Baniahmad A. Gene repression by nuclear hormone receptors. Essays Biochem. 2004, 40:89-104.
103. Guigon, C.J., et al., Tumor suppressor action of liganded thyroid hormone receptor {beta} by direct repression of {beta}-catenin gene expression. Endocrinology.
104. Guigon C.J., et al. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor. Mol. Cell. Biol. 2008, 28(14):4598-4608.
105. O'Shea P.J., et al. Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expression. Nucl. Recept. Signal. 2006, 4:e011.
106. Baxter J.D., Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat. Rev. Drug Discov. 2009, 8(4):308-320.
107. Malm J., et al. Thyroid hormone antagonists: potential medical applications and structure activity relationships. Curr. Med. Chem. 2009, 16(25):3258-3266.
108. Johansson L., et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc. Natl Acad. Sci. USA 2005, 102:10297-10302.
109. Berkenstam A., et al. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc. Natl Acad. Sci. USA 2008, 105:663-667.
110. Fearon E.R., Jones P.A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 1992, 6(10):2783-2790.